Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis
Crossref DOI link: https://doi.org/10.1007/s12072-017-9817-y
Published Online: 2017-08-30
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tang, Zilin
Li, Xiaodong
Wu, Shunquan
Liu, Yan
Qiao, Yan
Xu, Dongping
Li, Jin
Funding for this research was provided by:
National Natural Science Foundation of China (81373136, 81572010)
License valid from 2017-08-30